1 序文
2 範囲および方法論
2.1 本調査の目的
2.2 利害関係者
2.3 データソース
2.3.1 一次ソース
2.3.2 二次ソース
2.4 市場推定
2.4.1 ボトムアップアプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法論
3 エグゼクティブサマリー
4 はじめに
4.1 概要
4.2 主な業界動向
5 世界の臓器保存市場
5.1 市場概要
5.2 市場実績
5.3 COVID-19 の影響
5.4 市場予測
6 保存ソリューション別の市場内訳
6.1 UWソリューション
6.1.1 市場動向
6.1.2 市場予測
6.2 Custodiol HTK
6.2.1 市場動向
6.2.2 市場予測
6.3 Perfadex
6.3.1 市場動向
6.3.2 市場予測
6.4 その他
6.4.1 市場動向
6.4.2 市場予測
7 臓器提供の種類別市場
7.1 生体臓器提供
7.1.1 市場動向
7.1.2 市場予測
7.2 死亡臓器提供
7.2.1 市場動向
7.2.2 市場予測
8 技術別市場
8.1 静的低温保存技術
8.1.1 市場動向
8.1.2 市場予測
8.2 低体温マシン灌流
8.2.1 市場動向
8.2.2 市場予測
8.3 正常体温マシン灌流
8.3.1 市場動向
8.3.2 市場予測
8.4 その他
8.4.1 市場動向
8.4.2 市場予測
9 臓器タイプ別市場内訳
9.1 腎臓
9.1.1 市場動向
9.1.2 市場予測
9.2 肝臓
9.2.1 市場動向
9.2.2 市場予測
9.3 肺
9.3.1 市場動向
9.3.2 市場予測
9.4 心臓
9.4.1 市場動向
9.4.2 市場予測
9.5 その他
9.5.1 市場動向
9.5.2 市場予測
10 エンドユーザー別市場
10.1 病院およびクリニック
10.1.1 市場動向
10.1.2 市場予測
10.2 臓器バンク
10.2.1 市場動向
10.2.2 市場予測
10.3 その他
10.3.1 市場動向
10.3.2 市場予測
11 地域別市場
11.1 北米
11.1.1 米国
11.1.1.1 市場動向
11.1.1.2 市場予測
11.1.2 カナダ
11.1.2.1 市場動向
11.1.2.2 市場予測
11.2 アジア太平洋
11.2.1 中国
11.2.1.1 市場動向
11.2.1.2 市場予測
11.2.2 日本
11.2.2.1 市場動向
11.2.2.2 市場予測
11.2.3 インド
11.2.3.1 市場動向
11.2.3.2 市場予測
11.2.4 韓国
11.2.4.1 市場動向
11.2.4.2 市場予測
11.2.5 オーストラリア
11.2.5.1 市場動向
11.2.5.2 市場予測
11.2.6 インドネシア
11.2.6.1 市場動向
11.2.6.2 市場予測
11.2.7 その他
11.2.7.1 市場動向
11.2.7.2 市場予測
11.3 ヨーロッパ
11.3.1 ドイツ
11.3.1.1 市場動向
11.3.1.2 市場予測
11.3.2 フランス
11.3.2.1 市場動向
11.3.2.2 市場予測
11.3.3 イギリス
11.3.3.1 市場動向
11.3.3.2 市場予測
11.3.4 イタリア
11.3.4.1 市場動向
11.3.4.2 市場予測
11.3.5 スペイン
11.3.5.1 市場動向
11.3.5.2 市場予測
11.3.6 ロシア
11.3.6.1 市場動向
11.3.6.2 市場予測
11.3.7 その他
11.3.7.1 市場動向
11.3.7.2 市場予測
11.4 ラテンアメリカ
11.4.1 ブラジル
11.4.1.1 市場動向
11.4.1.2 市場予測
11.4.2 メキシコ
11.4.2.1 市場動向
11.4.2.2 市場予測
11.4.3 その他
11.4.3.1 市場動向
11.4.3.2 市場予測
11.5 中東およびアフリカ
11.5.1 市場動向
11.5.2 国別の市場内訳
11.5.3 市場予測
12 SWOT分析
12.1 概要
12.2 強み
12.3 弱み
12.4 機会
12.5 脅威
13 価値連鎖分析
14 ポーターのファイブフォース分析
14.1 概要
14.2 買い手の交渉力
14.3 売り手の交渉力
14.4 競争の度合い
14.5 新規参入の脅威
14.6 代替品の脅威
15 価格指標
16 競合状況
16.1 市場構造
16.2 主要企業
16.3 主要企業のプロフィール
21st Century Medicine Inc
Biolife Solutions Inc
Bridge to Life Ltd
Bristol-Myers
Dr. Franz Köhler Chemie GmbH
Essential Pharmaceuticals LLC
Lifeline Scientific Inc
OrganOx Ltd
Paragonix Technologies Inc
Transmedics. Inc
Waters Medical Systems LLC
Xvivo Perfusion
Organ preservation refers to the process of preserving healthy organs harvested from the body of donors. The process involves the removal of organs from the donor’s body, storing it for transportation and then transplanting it into the receiver’s body without significant damage. It utilizes various techniques, such as hypothermic machine perfusion, static cold storage (SCS) and normothermic machine perfusion (NMP), to maintain the temperature and oxygen levels of kidneys, liver, lung, heart and other organs. The preservation techniques and solutions used are essential for donor organ quality, which directly influences the morbidity and survival rates of a patient after transplantation.
Organ Preservation Market Trends:
The increasing prevalence of chronic diseases, along with the growing geriatric population across the globe, are among the key factors driving the growth of the market. Owing to the frequent occurrences of organ failures due to diabetes, cardiovascular disorders (CVDs), obesity, and other such severe medical conditions, there is an increasing need for organ preservation procedures. The advent of innovative and advanced techniques, such as NMP, for organ preservation, is acting as a growth-inducing factor. Such techniques aid in decreasing the probability of reperfusion injury during transplantation and exhibits improved results in cold storage for clinical and experimental studies. Moreover, an increasing number of government and non-government policies and initiatives to promote organ donation are impacting the market growth positively. The rising number of individuals volunteering to donate their organs for transplantation and research purposes are also driving the market further. Other factors, including enhanced research and development (R&D) and significant advancements in the organ preservation infrastructure, are also projected to contribute to the market growth significantly.
Organ Preservation Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global organ preservation market, along with forecast at the global, regional, and country levels from 2025-2033. The market has been categorized based on preservation solution, organ donation type, technique, organ type, and end-user.
Breakup by Preservation Solution:
UW Solution
Custodiol HTK
Perfadex
Others
Breakup by Organ Donation Type:
Living Organ Donation
Deceased Organ Donation
Breakup by Technique:
Static Cold Storage Technique
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
Breakup by Organ Type:
Kidney
Liver
Lung
Heart
Others
Breakup by End-User:
Hospitals and Clinics
Organ Banks
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being 21st Century Medicine, Biolife Solutions, Bridge to Life Ltd., Bristol-Myers Squibb, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals., Lifeline Scientific, OrganOx, Paragonix Technologies, TransMedics, Waters Medical Systems, Xvivo Perfusion, etc.
Key Questions Answered in This Report
1. What is organ preservation?
2. How big is the global organ preservation market?
3. What is the expected growth rate of the global organ preservation market during 2025-2033?
4. What are the key factors driving the global organ preservation market?
5. What is the leading segment of the global organ preservation market based on preservation solution?
6. What is the leading segment of the global organ preservation market based on organ donation type?
7. What is the leading segment of the global organ preservation market based on technique?
8. What is the leading segment of the global organ preservation market based on organ type?
9. What is the leading segment of the global organ preservation market based on end-user?
10. What are the key regions in the global organ preservation market?
11. Who are the key players/companies in the global organ preservation market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Organ Preservation Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Preservation Solution
6.1 UW Solution
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Custodiol HTK
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Perfadex
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Organ Donation Type
7.1 Living Organ Donation
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Deceased Organ Donation
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Technique
8.1 Static Cold Storage Technique
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hypothermic Machine Perfusion
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Normothermic Machine Perfusion
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Organ Type
9.1 Kidney
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Liver
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Lung
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Heart
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by End-User
10.1 Hospitals and Clinics
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Organ Banks
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 21st Century Medicine Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Biolife Solutions Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3 Bridge to Life Ltd.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Bristol-Myers
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Dr. Franz Köhler Chemie GmbH
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Essential Pharmaceuticals LLC
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Lifeline Scientific Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 OrganOx Ltd.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.9 Paragonix Technologies Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Transmedics, Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Waters Medical Systems LLC
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 Xvivo Perfusion
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
*** 臓器保存の世界市場に関するよくある質問(FAQ) ***
・臓器保存の世界市場規模は？
→IMARC社は2024年の臓器保存の世界市場規模を1億9887万米ドルと推定しています。
・臓器保存の世界市場予測は？
→IMARC社は2033年の臓器保存の世界市場規模を3億2040万米ドルと予測しています。
・臓器保存市場の成長率は？
→IMARC社は臓器保存の世界市場が2025年～2033年に年平均5.4%成長すると展望しています。
・世界の臓器保存市場における主要プレイヤーは？
→「21st Century Medicine Inc., Biolife Solutions Inc., Bridge to Life Ltd., Bristol-Myers, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals LLC, Lifeline Scientific Inc., OrganOx Ltd., Paragonix Technologies Inc., Transmedics, Inc., Waters Medical Systems LLC, Xvivo Perfusion.など ...」を臓器保存市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
